Skip to main content
Log in

Investigation of the Effect of Tamoxifen on hERG1 Potassium Channel Gene Expression in MCF-7 Cell Line

  • Published:
Russian Journal of Bioorganic Chemistry Aims and scope Submit manuscript

Abstract

Objective: Tamoxifen (TAM) is a nonstreroidal antiestrogenic pharmaceutical agent extensively employed in the therapeutic management of breast cancer. Alterations in the expression patterns of diverse ion channels have been implicated in the pathophysiology of breast cancer. The principal objective of this investigation was to elucidate the impact of TAM on the expression of the hERG1 potassium channel in the MCF-7 cell line. Methods: Cytotoxicity induced by TAM across various concentrations was assessed through the utilization of the MTT method. The patch clamp method was employed for electrophysiological analyses. The gene expression of the hERG1 potassium channel was quantified utilizing RT-qPCR. Results: The electrophysiological findings revealed reduction in potassium channel currents, reaching maximal inhibition at a TAM concentration of 5 μM. Concurrently, hERG1 potassium channel gene expression exhibited a decrease at the 5 μM TAM concentration. Despite statistical analysis, no statistically significant values were identified in both potassium channel currents and gene expression analyses when compared to the control group. Our results demonstrate that the blocking effect of TAM on potassium channel currents in the MCF-7 cell line was not determined. Conclusions: Further investigations are warranted to elucidate comprehensively the role of TAM in modulating hERG1 in breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

DATA AVAILABILITY

The data that support the findings of this study are available from the corresponding author upon reasonable request.

REFERENCES

  1. Ponce-Balbuena, D., López-Izquierdo, A., Ferrer, T., Rodríguez-Menchaca, A.A., AréchigaFigueroa, I.A., and Sánchez-Chapula, J.A. J. Pharmacol. Exp. Ther., 2009, vol. 331, pp. 563–73. https://doi.org/10.1124/jpet.109.156075

    Article  CAS  PubMed  Google Scholar 

  2. Fermini, B., Top. Med. Chem., 2008, vol. 3, pp. 1–25.

  3. Hassan, F., Mohammed, G., El-Hiti, G.A., Alshanon, A., and Yousif, E., J. Unexplored Med. Data, 2018, vol. 3, pp. 1–9. https://doi.org/10.20517/2572-8180.2017.25

    Article  Google Scholar 

  4. Mazzone, M., Menga, A., and Castegna, A., FEBS J., 2018, vol. 285, pp. 700–716. https://doi.org/10.1111/febs.14295

    Article  CAS  PubMed  Google Scholar 

  5. Prevarskaya, N., Skryma, R., and Shuba, Y., Cell Press, 2010, pp. 107–121. https://doi.org/10.1016/j.molmed.2010.01.005

  6. Schönherr, R., J. Membrane Biol., 2005, vol. 205, pp.175–184. https://doi.org/10.1007/s00232-005-0782-3

    Article  CAS  Google Scholar 

  7. Kunzelmann, K., J. Membrane Biol., 2005, vol. 205, pp. 159–173. https://doi.org/10.1007/s00232-005-0781-4

    Article  CAS  Google Scholar 

  8. Raschi, E., Vasina, V., Poluzzi, E., and De Ponti, F., Pharmacol. Res., 2008, vol. 57, pp. 181–195. https://doi.org/10.1016/j.phrs.2008.01.009

    Article  CAS  PubMed  Google Scholar 

  9. Wang, H., Zhang, Y., Cao, L., Han, H., Wang, J., Yang, B, Nattel, S., and Wang, Z., Cancer Res., 2002, vol. 62, pp. 4843–4848.

    CAS  PubMed  Google Scholar 

  10. Asher, V., Sowter, H., Shaw, R., Bali, A., and Khan, R., World J. Surg. Oncol., 2010, vol. 8, p. 113. https://doi.org/10.1186/1477-7819-8-113

    Article  PubMed  PubMed Central  Google Scholar 

  11. Felipe, A., Vicente, R., Villalonga, N., Roura-Ferrer, M., Martı’nez-Ma’rmol, R., Sole’ L, Ferreres, J.C., and Condom, E., Cancer Detect. Prev., 2006, vol. 30, pp. 375–385. https://doi.org/10.1016/j.cdp.2006.06.002

    Article  CAS  PubMed  Google Scholar 

  12. Wonderlin, W.F. and Strobl, J.S., J. Membr. Biol., 1996, vol. 154, pp. 91–107. https://doi.org/10.1007/s002329900135

    Article  CAS  PubMed  Google Scholar 

  13. Allen, M.C., Newland, C., Valverde, M.A., and Hardy, S.P., Eur. J. Pharmacol., 1998, vol. 354, pp. 261–269. https://doi.org/10.1016/s0014-2999(98)00454-3

    Article  CAS  PubMed  Google Scholar 

  14. Thomas, D., Gut, B., Karsai, S., Wimmer, A.B., Wu, K., Wendt-Nordahl, G., Zhang, W., Kathöfer, S., Schoels, W., Katus, H.A., Kiehn, J., and Karle, C.A., Naunyn Schmiedebergs Arch. Pharmacol., 2003, vol. 368, pp. 41–48. https://doi.org/10.1007/s00210-003-0766-8

    Article  CAS  PubMed  Google Scholar 

  15. Lee, H.J., Choi, J.S., Choi, B.H., and Hahn, S.J., Naunyn Schmiedebergs Arch., Pharmacol., 2017, vol. 390, pp. 633–642. https://doi.org/10.1007/s00210-017-1364-5

    Article  CAS  PubMed  Google Scholar 

  16. Wang, Z., Eur. J. Physiol., 2004, vol. 448, pp. 274–286. https://doi.org/10.1007/s00424-004-1258-5

    Article  CAS  Google Scholar 

  17. Pardo, L.A., Physiology, 2004, vol. 19, pp. 285–292. https://doi.org/10.1152/physiol.00011

    Article  CAS  PubMed  Google Scholar 

  18. Chae, Y.J., Lee, K.J., Lee, H.J., Sung, K.W., Choi, J.S., Lee, E.H., and Hahn, S.J., Eur. J. Pharmacol., 2015, vol.752, pp. 1–7. https://doi.org/10.1016/j.ejphar.2015.01.048

    Article  CAS  PubMed  Google Scholar 

  19. Pardo, L.A., del Camino, D., Sanchez, A., Alves, F., Bruggemann, A., Beckh, S., and Stuhmer, W., EMBO J., 1999, vol. 18, pp. 5540–5547. https://doi.org/10.1093/emboj/18.20.5540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Firth, A.L., Remillard, C.V., Platoshyn, O., Fantozzi, I., Eun, A., Ko, E.A., and Yuan, J.X.Y., Pulm. Circlulat., 2011, vol. 1, pp. 48–71. https://doi.org/10.4103/2045-8932.78103

    Article  CAS  Google Scholar 

  21. Smith, G.A.M., Tsui, H.W., Newell, E.W., Jiang, X., Zhu, X.P., Tsui, F.W.L., and Schlichter, L.C., J. Biol. Chem., 2002, vol. 277, pp. 18528–18534. https://doi.org/10.1074/jbc.M200592200

    Article  CAS  PubMed  Google Scholar 

  22. Ohkubo, T. and Yamazaki, J., Int. J. Oncol., 2012, vol. 41 pp. 267–275. https://doi.org/10.3892/ijo.2012.1422

    Article  CAS  PubMed  Google Scholar 

  23. Ouadid-Ahidouch, H., Chaussade, F., Roudbaraki, M., Slomianny, C., Dewailly, E., Delcourt, P., and Prevarskaya, N., Biochem. Biophys. Res. Commun., 2000, vol. 278, pp. 272–277. https://doi.org/10.1006/bbrc.2000.3790

    Article  CAS  PubMed  Google Scholar 

  24. Lastraioli, E., Lottini, T., Iorio, J., Freschi, G., Fazi, M., and Duranti, C., Oncotarget., 2016, vol.13, pp. 59535–59547.

    Article  Google Scholar 

  25. Crociani, O., Lastraioli, E., Boni, L., Pillozzi, S., Romoli, M.R., and D’Amico, M., Clin. Cancer Res., 2014, vol. 20, pp. 1502–1512. https://doi.org/10.1158/1078-0432.CCR-13-2633

    Article  CAS  PubMed  Google Scholar 

  26. Muratori, L., Petroni, G., Antonuzzo, L., Boni, L., Iorio, J., and Lastraioli, E., Oncol. Targets Ther., 2016, vol. 14, pp. 6325–6332. https://doi.org/10.2147/OTT.S114090

    Article  Google Scholar 

  27. Iorio, J., Meattini, I., Bianchi, S., Bernini, M., Maragna, V., Dominici, L., Casella, D., Vezzosi, V., Orzalesi, L., Nori, J., Livi, L., Arcangeli, A., and Lastraioli, E., Cancer Cell Int., 2018, vol. 18, p. 93. https://doi.org/10.1186/s12935-018-0592-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Feng, J., Yu, J., Pan, X., Li, Z., Chen, Z., Zhang, W., Wang, B., Yang, L., Xu, H., Zhang, G., and Xu, Z., Oncotarget., 2014, vol. 5, pp. 5832–5844. https://doi.org/10.18632/oncotarget.2200

    Article  PubMed  PubMed Central  Google Scholar 

  29. Shao, X.D., Wu, K.C., Guo, X.Z., Xie, M.J., Zhang, J., and Fan, D.M., Cancer Biol. Ther., 2008, vol. 7, pp. 45–50. https://doi.org/10.4161/cbt.7.1.5126

    Article  CAS  PubMed  Google Scholar 

  30. Abdullah, Y., Cureus, 2023, vol. 15, p. e47501. https://doi.org/10.7759/cureus.47501

  31. Tsang, S.Y., Yao, X., Wong, C.M., Chan, F.L., Chen, Z.Y., and Huang, Y., Eur. J. Pharmacol., 2004, vol. 483, pp. 155–162. https://doi.org/10.1016/j.ejphar.2003.10.031

    Article  CAS  PubMed  Google Scholar 

  32. Vajrabhaya, L. and Korsuwannawong, S., JAST, 2018, pp. 9–15. https://doi.org/10.1186/s40543-018-0146-0

  33. Helliwell, R.M., Potassium Channels: Method. Protocol., 2009, pp. 279–295.

  34. Zhang, X., Yu, D., Geng, H., Li, F., Lv, L., Zhao, L., Yan, C., and Li, B., Oncol. Lett., 2018, vol. 16, pp. 3812–3820.

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

The authors would like to thank to Mersin University Scientific Research Project Unit for financial support (no. BAP-SBEBK(PE)2011-3DR).

Author information

Authors and Affiliations

Authors

Contributions

The authors PE, FS, SY, UC, and NSY designed the experiments. The authors PE, FS, DY, and NSY carried out their biological study. The authors PE, SY, FS, UC, NSY, and SE participated in data processing and contributed to manuscript preparation.

All authors participated in the discussions.

Corresponding author

Correspondence to P. Eroglu.

Ethics declarations

This article does not contain any studies involving patients or animals as test objects.

Informed consent was not required for this article. No conflict of interest was declared by the authors

Additional information

Publisher's Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eroglu, P., Sogut, F., Yetkin, D. et al. Investigation of the Effect of Tamoxifen on hERG1 Potassium Channel Gene Expression in MCF-7 Cell Line. Russ J Bioorg Chem 50, 392–400 (2024). https://doi.org/10.1134/S106816202402016X

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S106816202402016X

Keywords:

Navigation